These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas? Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499 [TBL] [Abstract][Full Text] [Related]
6. Molecular Cytogenetic Analysis of JAZF1, PHF1, and YWHAE in Endometrial Stromal Tumors: Discovery of Genetic Complexity by Fluorescence in Situ Hybridization. Hodge JC; Bedroske PP; Pearce KE; Sukov WR J Mol Diagn; 2016 Jul; 18(4):516-26. PubMed ID: 27154512 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases. Stewart CJ; Leung YC; Murch A; Peverall J Histopathology; 2014 Oct; 65(4):473-82. PubMed ID: 24592973 [TBL] [Abstract][Full Text] [Related]
8. Frequency of known gene rearrangements in endometrial stromal tumors. Chiang S; Ali R; Melnyk N; McAlpine JN; Huntsman DG; Gilks CB; Lee CH; Oliva E Am J Surg Pathol; 2011 Sep; 35(9):1364-72. PubMed ID: 21836477 [TBL] [Abstract][Full Text] [Related]
9. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria. Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177 [TBL] [Abstract][Full Text] [Related]
10. [Clinical value of fluorescence Wang W; Li X; Liu P; Dong Y Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132 [TBL] [Abstract][Full Text] [Related]
11. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma. Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885 [TBL] [Abstract][Full Text] [Related]
12. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas. Song MJ; Cho KJ; Lee JS; Song JS Appl Immunohistochem Mol Morphol; 2017; 25(10):712-719. PubMed ID: 27028243 [TBL] [Abstract][Full Text] [Related]
13. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748 [TBL] [Abstract][Full Text] [Related]
14. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features. Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706 [TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry. Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521 [TBL] [Abstract][Full Text] [Related]
17. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics. Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411 [TBL] [Abstract][Full Text] [Related]
18. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall. Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315 [TBL] [Abstract][Full Text] [Related]